Astrazeneca (AZN) Gross Margin (2009 - 2026)
Astrazeneca (AZN) reported Gross Margin of 88.03% for Q3 2026, up 1.78 percentage points from 86.25% a year earlier and up 4.43 percentage points from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Gross Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Astrazeneca's Gross Margin came in at 86.10%, down 0.88 percentage points year-over-year; for FY2025, it was 81.90%, up 0.77 percentage points from FY2024.
- Gross Margin has a five-year change of +1.81 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 81.12% in FY2024 (-0.83 pp), 81.95% in FY2023 (+9.89 pp), 72.06% in FY2022 (+5.30 pp) and 66.76% in FY2021 (-13.33 pp).
- The Q3 2026 figure ranks as the highest quarterly Gross Margin since Q1 2025.
- Year over year, Gross Margin gained in five of the last eight quarters, with an average year-over-year change of +1.08 percentage points.
- The high point for year-over-year Gross Margin in five years was Q1 2023 (a gain of 15.76 percentage points); the low point was Q4 2021 (a drop of 19.70 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 83.60% (Q2 2026), 87.65% (Q1 2026) and 85.19% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 75.71% |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 84.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 88.03% |
| Jun 30, 2026 | 83.60% |
| Mar 31, 2026 | 87.65% |
| Dec 31, 2025 | 85.19% |
| Sep 30, 2025 | 86.25% |
| Jun 30, 2025 | 82.89% |
| Mar 31, 2025 | 88.13% |
| Dec 31, 2024 | 91.05% |
| Sep 30, 2024 | 80.98% |
| Jun 30, 2024 | 83.13% |
| Mar 31, 2024 | 85.91% |
| Dec 31, 2023 | 85.81% |
| Sep 30, 2023 | 85.29% |
| Jun 30, 2023 | 82.83% |
| Mar 31, 2023 | 84.93% |
| Dec 31, 2022 | 74.12% |
| Sep 30, 2022 | 72.85% |
| Jun 30, 2022 | 72.17% |
| Mar 31, 2022 | 69.17% |
| Dec 31, 2021 | 64.24% |
API Access
Astrazeneca Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();